Medical Weight Loss for Grand Forks, North Dakota Residents

Grand Forks, North Dakota residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Grand Forks through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Flexible payment for Grand Forks residents: we accept HSA, FSA, Klarna, and Affirm, so paying for your North Dakota telehealth program can fit your budget. Medication is billed separately. Doctor review just $119 (medication separate).

Why Grand Forks Residents Choose New Hope Weight Loss

New Hope was designed around the way Grand Forks residents actually live. You book your physician visit online, meet Dr. Anjmun Sharma by video, and if treatment makes sense your medication ships to your door. Everything runs through our Costa Mesa clinic by telehealth, so there is no local office to visit and no day off work required. The convenience is real, but the medical care behind it is the part we protect most.

Grand Forks is served through telehealth from our Costa Mesa, California clinic. The full physician-supervised GLP-1 program runs by secure video, with compounded medication shipped to your Grand Forks address.

If you are searching for a weight-loss physician in Grand Forks, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts North Dakota patients exactly where local ones are. We care for patients throughout the greater Grand Forks area and the Red River Valley. Every prescription is reviewed and authorized by Dr. Anjmun Sharma, MD, before anything is sent to your address in North Dakota.

By handling visits through telehealth, we serve every neighborhood in Grand Forks, from the greater Grand Forks area and the Red River Valley, without asking anyone to travel. Patients anywhere in North Dakota, including the the greater Grand Forks area and the Red River Valley neighborhoods, get the same pricing because care is delivered by telehealth from our Costa Mesa clinic. Even across the wide distances of North Dakota, New Hope Weight Loss reaches patients by secure telehealth from our Costa Mesa, California clinic, so geography never limits your care.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Grand Forks meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Grand Forks

Step 1: The quiz. Tell us about your health history, current weight, and goals through a quick online intake.

Step 2: The video visit. Dr. Sharma reviews your intake and meets you by secure video, usually within 48 hours, to discuss whether compounded semaglutide or tirzepatide is a fit. Results vary from person to person.

Step 3: Delivery. A state-licensed 503(a) pharmacy ships your medication to your Grand Forks address in cold-pack packaging.

Step 4: Follow-ups. You stay in touch by video as you progress.

Frequently Asked Questions, Grand Forks

I live in Grand Forks. Is the nearest New Hope Weight Loss office close by?

The nearest office is in Costa Mesa, California, which is our only physical site. That said, you do not have to be near it. We treat Grand Forks, North Dakota patients by telehealth, and a video consult with Dr. Anjmun Sharma confirms whether you are a candidate for compounded semaglutide or tirzepatide.

Will I ever need to show up in person if I am in Grand Forks?

No in-person visits are needed for Grand Forks residents. The entire program is telehealth, from your first consult to refills and check-ins. When you qualify, your medication ships to Grand Forks in cold-pack packaging designed to maintain the proper temperature throughout shipping.

What are the prices for Grand Forks residents?

A physician review costs $119. Compounded semaglutide is priced from $166 per month or $499 for a 90-day course, and tirzepatide from $233 per month. Medication is charged on its own. Payment through HSA, FSA, Klarna, or Affirm is accepted, and we never add a distance surcharge for Grand Forks.

What areas of Grand Forks do you serve?

We serve patients from across Grand Forks by telehealth, including the greater Grand Forks area and the Red River Valley.

Are there hidden fees for Grand Forks patients?

No. Grand Forks patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Grand Forks Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Grand Forks, North Dakota by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.